Correlation Between Arcus Biosciences and Virax Biolabs

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and Virax Biolabs Group, you can compare the effects of market volatilities on Arcus Biosciences and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Virax Biolabs.

Diversification Opportunities for Arcus Biosciences and Virax Biolabs

-0.19

Correlation Coefficient

Arcus Biosciences  Virax Biolabs

Good diversification

The 3 months correlation between Arcus and Virax is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Virax Biolabs go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Virax Biolabs

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.31 times more return on investment than Virax Biolabs. However, Arcus Biosciences is 3.18 times less risky than Virax Biolabs. It trades about 0.11 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.04 per unit of risk. If you would invest  1,456  in Arcus Biosciences on September 24, 2024 and sell it today you would earn a total of  94.00  from holding Arcus Biosciences or generate 6.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arcus Biosciences  vs.  Virax Biolabs Group

Arcus Biosciences

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arcus Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Virax Biolabs Group

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Arcus Biosciences and Virax Biolabs

The main advantage of trading using opposite Arcus Biosciences and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.

The idea behind Arcus Biosciences and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.